Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 2
1972 2
1978 1
1979 1
1981 1
1987 1
1993 1
2004 1
2014 1
2016 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
Bortezomib Treatment Sensitizes Oncolytic HSV-1-Treated Tumors to NK Cell Immunotherapy.
Yoo JY, Jaime-Ramirez AC, Bolyard C, Dai H, Nallanagulagari T, Wojton J, Hurwitz BS, Relation T, Lee TJ, Lotze MT, Yu JG, Zhang J, Croce CM, Yu J, Caligiuri MA, Old M, Kaur B. Yoo JY, et al. Among authors: hurwitz bs. Clin Cancer Res. 2016 Nov 1;22(21):5265-5276. doi: 10.1158/1078-0432.CCR-16-1003. Epub 2016 Jul 7. Clin Cancer Res. 2016. PMID: 27390350 Free PMC article.
Bortezomib-induced unfolded protein response increases oncolytic HSV-1 replication resulting in synergistic antitumor effects.
Yoo JY, Hurwitz BS, Bolyard C, Yu JG, Zhang J, Selvendiran K, Rath KS, He S, Bailey Z, Eaves D, Cripe TP, Parris DS, Caligiuri MA, Yu J, Old M, Kaur B. Yoo JY, et al. Among authors: hurwitz bs. Clin Cancer Res. 2014 Jul 15;20(14):3787-98. doi: 10.1158/1078-0432.CCR-14-0553. Epub 2014 May 9. Clin Cancer Res. 2014. PMID: 24815720 Free PMC article.
Tear-duct fibrosis (dacryostenosis) due to 5-fluorouracil.
Haidak DJ, Hurwitz BS, Yeung KY. Haidak DJ, et al. Among authors: hurwitz bs. Ann Intern Med. 1978 May;88(5):657. doi: 10.7326/0003-4819-88-5-657_1. Ann Intern Med. 1978. PMID: 646255 No abstract available.
13 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page